CYP2C19 but not PON1 genetic variants influence clopidogrel pharmacokinetics, pharmacodynamics, and clinical efficacy in post-myocardial infarction patients - Hulot, JS; Collet, JP; Cayla, G (Circ Cardiovasc Interv, 2011)
et al.